Transcriptome Analysis of Retinoic Acid-Inducible Gene I Overexpression Reveals the Potential Genes for Autophagy-Related Negative Regulation

Cells. 2022 Jun 23;11(13):2009. doi: 10.3390/cells11132009.

Abstract

Retinoic acid-inducible gene I (RIG-I) serves as an essential viral RNA sensor for innate immune. The activation of the RIG-I-like receptors (RLRs) pathway triggers many regulations for the outcome of type I interferon, including ubiquitination, dephosphorylation, ISGylation, and autophagy. However, the autophagy-related regulation of RIG-I is still not fully understood. To investigate the potentially unknown genes related to autophagy-related regulation of RIG-I, we firstly confirm the induction of autophagy derived by overexpression of RIG-I. Furthermore, the autophagy inducer and inhibitor drugs were used in different assays. The results showed autophagy could control the activation of RLRs pathway and expression of exogenous RIG-I. In addition, we carried out the transcriptome analysis of overexpression of RIG-I in vitro. Differentially expressed genes (DEGs) in GO and KEGG signaling pathways enrichment provided a newly complex network. Finally, the validation of qPCR indicated that the DEGs PTPN22, PRKN, OTUD7B, and SIRT2 were correlated to the negative regulation of excessive expression of RIG-I. Taken together, our study contributed new insights into a more comprehensive understanding of the regulation of excessive expression of RIG-I. It provided the potential candidate genes for autophagy-related negative regulation for further investigation.

Keywords: RIG-I; autophagy; negative regulation; overexpression; transcriptome analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy / genetics
  • Gene Expression Profiling*
  • Interferon Type I*
  • Signal Transduction / genetics
  • Tretinoin

Substances

  • Interferon Type I
  • Tretinoin

Grants and funding

This work was supported by the grants from Natural Sciences Science Foundation of Guangdong Province (no. 2018B030311037), the National Natural Science Foundation of China (no. 31872454 and 31672563), the National Key Research and Development Program of China (no. 2016YFD0501004), and Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases (no. 2017B030314142).